Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-vsgnj Total loading time: 0 Render date: 2024-07-23T23:11:17.593Z Has data issue: false hasContentIssue false

Chapter 24 - Chronic Inflammatory Demyelinating Polyradiculoneuropathy

from Section 5 - Chronic Immune Neuropathies

Published online by Cambridge University Press:  20 April 2018

Mark B. Bromberg
Mark B. Bromberg
Affiliation:
University of Utah
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Peripheral Neuropathies
A Practical Approach
 , pp. 123 - 128
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision. J Peripher Nerv Syst. 2010;15(3):185–95.Google Scholar
Anderson, CR, Olson, JA. Correlation of weight-based i.v. immune globulin doses with changes in serum immunoglobulin G levels. Am J Health Syst Pharm. 2015;72(4):285–9.CrossRefGoogle ScholarPubMed
Beydoun, SR, Muir, J, Apelian, RG, Go, JL, Lin, FP. Clinical and imaging findings in three patients with advanced inflammatory demyelinating polyradiculoneuropathy associated with nerve root hypertrophy. J Clin Neuromuscul Dis. 2012;13(3):105–12.CrossRefGoogle ScholarPubMed
Boru, UT, Erdogan, H, Alp, R, Tasdemir, M, Yildirim, S, Bilgic, A, et al. Treatment of chronic inflammatory demyelinating polyneuropathy with high dose intravenous methylprednisolone monthly for five years: 10-Year follow up. Clin Neurol Neurosurg. 2014;118:89–93.CrossRefGoogle Scholar
Breiner, A, Brannagan, TH, III. Comparison of sensitivity and specificity among 15 criteria for chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2014;50(1):40–6.CrossRefGoogle ScholarPubMed
Bromberg, MB. Review of the evolution of electrodiagnostic criteria for chronic inflammatory demyelinating polyradicoloneuropathy. Muscle Nerve. 2011;43(6):780–94.CrossRefGoogle ScholarPubMed
Bromberg, MB, Brownell, AA. Role of electroidagnosis in the evaluation of peripheral neuropathies. Intestbook of Peripheral Neuropathy, Donofrio PD (ed). New York: Demosmedical; 2012.Google Scholar
Bromberg, MB, Carter, O. Corticosteroid use in the treatment of neuromuscular disorders: empirical and evidence-based data. Muscle Nerve. 2004;30(1):20–37.CrossRefGoogle ScholarPubMed
Bromberg, MB, Feldman, EL, Albers, JW. Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy. Neurology. 1992;42(6):1157–63.CrossRefGoogle ScholarPubMed
Cocito, D, Grimaldi, S, Paolasso, I, Falcone, Y, Antonini, G, Benedetti, L, et al. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis. Eur J Neurol. 2011;18(12):1417–21.CrossRefGoogle ScholarPubMed
Cornblath, DR, Gorson, KC, Hughes, RA, Merkies, IS. Observations on chronic inflammatory demyelinating polyneuropathy: A plea for a rigorous approach to diagnosis and treatment. J Neurol Sci. 2013;330(1–2):2–3.CrossRefGoogle ScholarPubMed
Di Pasquale, A, Morino, S, Loreti, S, Bucci, E, Vanacore, N, Antonini, G. Peripheral nerve ultrasound changes in CIDP and correlations with nerve conduction velocity. Neurology. 2015;84(8):803–809.CrossRefGoogle ScholarPubMed
Dyck, PJ, Lais, AC, Ohta, M, Bastron, JA, Okazaki, H, Groover, RV. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc. 1975;50(11):621–37.Google ScholarPubMed
Eftimov, F, Vermeulen, M, van Doorn, PA, Brusse, E, van Schaik, IN. Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment. Neurology. 2012;78(14):1079–84.Google Scholar
Eftimov, F, Winer, JB, Vermeulen, M, de Haan, R, van Schaik, IN. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2013;12:CD001797.Google Scholar
Hughes, RA, Bouche, P, Cornblath, DR, Evers, E, Hadden, RD, Hahn, A, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol. 2006;13(4):326–32.CrossRefGoogle ScholarPubMed
Hughes, RA, Donofrio, P, Bril, V, Dalakas, MC, Deng, C, Hanna, K, et al. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol. 2008;7(2):136–44.CrossRefGoogle Scholar
Hughes, RA, Mehndiratta, MM. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2015;1:CD002062.Google Scholar
Jang, JH, Cho, CS, Yang, KS, Seok, HY, Kim, BJ. Pattern analysis of nerve enlargement using ultrasonography in chronic inflammatory demyelinating polyneuropathy. Clin Neurophysiol. 2014;125(9):1893–9.CrossRefGoogle ScholarPubMed
Lozeron, P, Lacour, MC, Vandendries, C, Theaudin, M, Cauquil, C, Denier, C, et al. Contribution of plexus MRI in the diagnosis of atypical chronic inflammatory demyelinating polyneuropathies. J Neurol Sci. 2016;360:170–5.CrossRefGoogle ScholarPubMed
Mahdi-Rogers, M, van Doorn, PA, Hughes, RA. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2013;6:CD003280.Google Scholar
Mathey, EK, Park, SB, Hughes, RA, Pollard, JD, Armati, PJ, Barnett, MH, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. J Neurol Neurosurg Psychiatry. 2015.Google Scholar
Mehndiratta, MM, Hughes, RA. Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2012;9:CD003906.Google Scholar
Muley, SA, Kelkar, P, Parry, GJ. Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids. Arch Neurol. 2008;65(11):1460–4.CrossRefGoogle ScholarPubMed
Querol, L, Rojas-Garcia, R, Casasnovas, C, Sedano, MJ, Munoz-Blanco, JL, Alberti, MA, et al. Long-term outcome in chronic inflammatory demyelinating polyneuropathy patients treated with intravenous immunoglobulin: a retrospective study. Muscle Nerve. 2013;48(6):870–6.CrossRefGoogle ScholarPubMed
Rajabally, YA. Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospects. J Neurol Neurosurg Psychiatry. 2014;85(6):631–7.CrossRefGoogle ScholarPubMed
Rajabally, YA. Long-term Immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 2015;51(5):657–61.CrossRefGoogle ScholarPubMed
Ruts, L, Drenthen, J, Jacobs, BC, van Doorn, PA. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology. 2010;74(21):1680–6.CrossRefGoogle ScholarPubMed
Van den Bergh, PY, Hadden, RD, Bouche, P, Cornblath, DR, Hahn, A, Illa, I, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision. Eur J Neurol. 2010;17(3):356–63.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×